Eli Lilly Shares (Diluted) decreased by 0.3% to 895.9M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.5%, from 900.6M to 895.9M. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.
The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...
Standard metric for all public companies; essential for understanding the impact of equity-based compensation.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 910.4M | 910.8M | 906.4M | 902.9M | 903.8M | 119K | 903.3M | 902.7M | 899.8M | 200K | 903.8M | 904.2M | 905M | 900.6M | 899.8M | 898.8M | 895.9M |
| QoQ Change | — | +0.0% | -0.5% | -0.4% | +0.1% | -100.0% | >999% | -0.1% | -0.3% | -100.0% | >999% | +0.0% | +0.1% | -0.5% | -0.1% | -0.1% | -0.3% |
| YoY Change | — | — | — | -0.8% | -0.8% | — | -0.3% | -0.0% | -0.4% | +68.1% | +0.1% | +0.2% | +0.6% | -0.4% | -0.5% | -0.7% | -0.5% |